Page last updated: 2024-08-21

c.i. 42510 and Angiogenesis, Pathologic

c.i. 42510 has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Chen, X; Fang, J; Guo, G; Li, X; Liang, Y; Wang, L; Xiang, J; Zhang, B; Zhang, L; Zhang, W	1

Other Studies

1 other study(ies) available for c.i. 42510 and Angiogenesis, Pathologic

Article	Year
P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway. The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:6 Topics: Animals; Cell Line, Tumor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioma; Hypoxia-Inducible Factor 1, alpha Subunit; Indicators and Reagents; Male; Neovascularization, Pathologic; Purinergic P2X Receptor Antagonists; Radiography; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Vascular Endothelial Growth Factor A	2013

Article

Year

P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway.

The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:6

Topics: Animals; Cell Line, Tumor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioma; Hypoxia-Inducible Factor 1, alpha Subunit; Indicators and Reagents; Male; Neovascularization, Pathologic; Purinergic P2X Receptor Antagonists; Radiography; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Vascular Endothelial Growth Factor A

2013